These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17570626)

  • 21. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
    Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
    Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of serine proteases: activity of 1,3-diazetidine-2,4-diones.
    Aoyama Y; Uenaka M; Konoike T; Hayasaki-Kajiwara Y; Naya N; Nakajima M
    Bioorg Med Chem Lett; 2001 Jul; 11(13):1691-4. PubMed ID: 11425539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (-)Epigallocatechin-3-gallate inhibits leukocyte elastase: potential of the phyto-factor in hindering inflammation, emphysema, and invasion.
    Sartor L; Pezzato E; Garbisa S
    J Leukoc Biol; 2002 Jan; 71(1):73-9. PubMed ID: 11781382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of homecare costs of local wound care in surgical patients randomized between occlusive and gauze dressings.
    Ubbink DT; Vermeulen H; van Hattem J
    J Clin Nurs; 2008 Mar; 17(5):593-601. PubMed ID: 18279292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide-Cellulose Conjugates on Cotton-Based Materials Have Protease Sensor/Sequestrant Activity.
    Edwards JV; Fontenot KR; Liebner F; Condon BD
    Sensors (Basel); 2018 Jul; 18(7):. PubMed ID: 30021995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel locust (Schistocerca gregaria) serine protease inhibitor with a high affinity for neutrophil elastase.
    Brillard-Bourdet M; Hamdaoui A; Hajjar E; Boudier C; Reuter N; Ehret-Sabatier L; Bieth JG; Gauthier F
    Biochem J; 2006 Dec; 400(3):467-76. PubMed ID: 16839309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-melanocyte-stimulating hormone down-regulates CXC receptors through activation of neutrophil elastase.
    Manna SK; Sarkar A; Sreenivasan Y
    Eur J Immunol; 2006 Mar; 36(3):754-69. PubMed ID: 16479540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one.
    Groutas WC; Chong LS; Venkataraman R
    Biochem Biophys Res Commun; 1993 Dec; 197(2):730-9. PubMed ID: 8267609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of polynucleotides on the inhibition of neutrophil elastase by mucus proteinase inhibitor and alpha 1-proteinase inhibitor.
    Belorgey D; Bieth JG
    Biochemistry; 1998 Nov; 37(46):16416-22. PubMed ID: 9819234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wound dressings. Past, present, and future.
    Horncastle J
    Med Device Technol; 1995; 6(1):30-4, 36. PubMed ID: 10155372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial of the absorbency of four dressings and their effects on the evaporation of burn wounds.
    Chen J; Han CM; Su GL; Tang ZJ; Su SJ; Lin XW
    Chin Med J (Engl); 2007 Oct; 120(20):1788-91. PubMed ID: 18028772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of human serine proteases by SPAAT, the C-terminal 44-residue peptide from alpha1-antitrypsin.
    Niemann MA; Baggott JE; Miller EJ
    Biochim Biophys Acta; 1997 Jun; 1340(1):123-30. PubMed ID: 9217022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteases and pH in chronic wounds.
    Greener B; Hughes AA; Bannister NP; Douglass J
    J Wound Care; 2005 Feb; 14(2):59-61. PubMed ID: 15739652
    [No Abstract]   [Full Text] [Related]  

  • 34. Potential of pyrazolooxadiazinone derivatives as serine protease inhibitors.
    Vicentini CB; Guarneri M; Andrisano V; Guccione S; Langer T; Marschhofer R; Chabin R; Edison AM; Huang X; Knight WB; Giori P
    J Enzyme Inhib; 2001 Jan; 16(1):15-34. PubMed ID: 11496832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New therapeutic strategies for the treatment of difficult wounds].
    Onesti MG; Bitonti A; Fino P; Ciotti M; Scuderi N
    G Chir; 2008 May; 29(5):212-20. PubMed ID: 18507956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds.
    Cole AM; Shi J; Ceccarelli A; Kim YH; Park A; Ganz T
    Blood; 2001 Jan; 97(1):297-304. PubMed ID: 11133774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly potent irreversible inhibitors of neutrophil elastase generated by selection from a randomized DNA-valine phosphonate library.
    Charlton J; Kirschenheuter GP; Smith D
    Biochemistry; 1997 Mar; 36(10):3018-26. PubMed ID: 9062133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions.
    Korkmaz B; Moreau T; Gauthier F
    Biochimie; 2008 Feb; 90(2):227-42. PubMed ID: 18021746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-healing foot ulcers in diabetic patients: general and local interfering conditions and management options with advanced wound dressings.
    Uccioli L; Izzo V; Meloni M; Vainieri E; Ruotolo V; Giurato L
    J Wound Care; 2015 Apr; 24(4 Suppl):35-42. PubMed ID: 25853647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4-68 variant.
    Lim JK; Lu W; Hartley O; DeVico AL
    J Leukoc Biol; 2006 Dec; 80(6):1395-404. PubMed ID: 16963625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.